Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
8 intermediate papers

Works of Concepción Rivas being referenced

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial
2006
Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
2005
and 2 more

Author Peers

Author Last Decade Papers Cites
Concepción Rivas 259 201 35 123 18 344
Manabu Sotomatsu 249 131 46 159 22 381
Shu‐Huey Chen 215 111 63 92 29 324
F. C. de Waal 123 156 39 128 23 327
S. K. 174 103 59 84 23 328
Henrik Schr�der 149 232 46 93 13 369
José González‐Campos 181 171 56 55 23 309
Jiann-Shiuh Chen 117 121 46 94 23 346
Nathalie Aladjidi 210 110 27 57 12 360
Teresa Santostasi 98 113 26 62 19 332
Gen Kano 75 113 29 150 20 372

All Works

Loading papers...

Rankless by CCL
2026